t
| Date | 25 May 2023 |
| Time | 16:15:48 |
| Category | AGMs and other meetings |
| ID | 7151A |
Life Science REIT plc
(the "Company")
LEI: 213800RG7JNX7K8F7525
25 May 2023
Annual General Meeting ("AGM") Results
The Company announces that at its Annual General Meeting held earlier today all the resolutions set out in the Notice of Annual General Meeting were passed. All resolutions were voted on by way of a poll. The results of the poll for each resolution were as follows:
|
Resolution
|
For |
Against
|
Votes Withheld (No. of shares)
|
||
|
No. of shares |
%
|
No. of shares |
% |
||
|
1. To receive and approve the annual report and financial statements
|
237,307,165 |
100.00% |
10,345 |
0.00% |
19,548 |
|
2. To receive and approve the Directors' remuneration report |
236,497,636 |
99.68% |
761,688 |
0.32% |
77,734 |
|
3. To re-elect Claire Boyle as a Director of the Company |
227,063,288 |
95.69% |
10,227,912 |
4.31% |
45,858 |
|
4. To re-elect Sally Ann Forsyth as a Director of the Company |
197,662,892 |
90.55% |
20,630,888 |
9.45% |
19,043,278 |
|
5. To re-elect Michael Taylor as a Director of the Company |
236,321,834 |
99.59% |
969,366 |
0.41% |
45,858 |
|
6. To re-elect Richard Howell as a Director of the Company |
236,350,144 |
99.59% |
969,366 |
0.41% |
17,548 |
|
7. To appoint Deloitte LLP as Auditor to the Company
|
237,257,249 |
99.97% |
63,261 |
0.03% |
16,548 |
|
8. To authorise the Audit and Risk Committee to determine the remuneration of the Auditor to the Company
|
237,267,855 |
99.99% |
24,345 |
0.01% |
44,858 |
|
9. To approve the Company's dividend payment policy |
237,287,855 |
100.00% |
10,345 |
0.00% |
38,858 |
|
10. To authorise the Directors to allot equity securities |
228,003,637 |
96.08% |
9,294,563 |
3.92% |
38,858 |
|
11. To authorise the Directors to disapply pre-emption rights*
|
226,872,038 |
95.61% |
10,420,162 |
4.39% |
44,858 |
|
12. To authorise the Directors to disapply pre-emption rights for the purposes of financing an acquisition or other capital investment*
|
225,728,875 |
95.13% |
11,563,325 |
4.87% |
44,858 |
|
13. To approve the purchase of the Company's own shares*
|
227,477,570 |
95.87% |
9,800,639 |
4.13% |
58,849 |
|
14. That a general meeting, other than an AGM, may be called on not less than 14 clear days' notice* |
236,894,091 |
99.83% |
404,109 |
0.17% |
38,858 |
*special resolution
|
NOTES:
|
|
|
1. |
All resolutions were passed.
|
|
2.
|
Percentages have been rounded to two decimal places. |
|
3. |
Proxy appointments which gave discretion to the Chair of the AGM have been included in the "For" total for the appropriate resolution.
|
|
4. |
Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.
|
|
5. |
A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against" any resolution.
|
|
6. |
The number of shares in issue at 6:00 pm. on 23 May 2023 was 350,000,000 ordinary shares, carrying one vote each, and at that time, the Company did not hold any shares in treasury.
|
|
7. |
The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at https://lifesciencereit.co.uk/investors/shareholder-information/
|